
Aesthetic Insight is an all-encompassing, cloud-based software platform that complies with HIPAA standards, specifically tailored for aesthetic clinics and medical spas, incorporating a variety of features such as scheduling, online booking, point-of-sale, and membership management into a unified system. This innovative solution enables clinics to efficiently manage online appointments based on resource availability, digitize their intake and consent processes, and handle bundled service memberships with automated billing functionality. Furthermore, the platform supports online retail sales through its integrated e-commerce features while boosting client engagement through customized marketing strategies. By bringing together front-desk operations, treatment records, and inventory management within one interface, it greatly simplifies the day-to-day operations of clinics. Additionally, the software boasts sophisticated features like calendar management, client segmentation, automated reminders, and tracking for package redemptions, all of which contribute to a seamless interaction for both staff and clients. This comprehensive approach not only enhances operational efficiency but also strengthens the connections between clinics and their clients, ultimately leading to improved service delivery. In doing so, it empowers clinics to focus more on patient care and less on administrative burdens.
Learn more
Elation Health stands out as the premier platform for primary care, enabling 32,000 healthcare providers to offer tailored care to more than 16 million patients. By utilizing a clinically-focused electronic health record system, along with integrated billing solutions and AI-driven tools, Elation enhances care processes, ensuring that independent practices can flourish in a competitive landscape. This commitment to innovation not only improves patient outcomes but also streamlines operations for practitioners.
Learn more
ARIA Clinical Solutions
The ARIA® oncology information system is tailored to support both medical and radiation oncology, including proton therapy, ensuring a broad spectrum of functionalities. It facilitates the review and management of clinical images, prescriptions, lab results, quality assurance data, and patient outcomes, among other important information. Cancer staging is automatically aligned with AJCC guidelines, and the system offers flexible management options for toxicities. With a strong focus on interoperability, ARIA enables seamless use of patient data across a variety of devices and platforms. It provides robust support for HL7 and DICOM standards, which simplifies the transfer of patient information between different healthcare facilities. By granting immediate access to patient data, the system empowers healthcare teams to improve their planning capabilities and make real-time adjustments. Additionally, ARIA enhances the effectiveness of image-guided treatment techniques by efficiently utilizing radiographic, fluoroscopic, and cone-beam CT images. The system also keeps track of essential activities for evidence-based Pay-for-Performance programs, all while maintaining compliance with HIPAA regulations. Moreover, ARIA systematically organizes and stores patient data and images, ensuring that healthcare teams remain well-informed and focused on delivering optimal care. This all-encompassing approach not only streamlines workflows but also plays a significant role in improving patient outcomes, ultimately leading to a more effective oncology care experience.
Learn more
Omda Cytodose
Omda Cytodose is an oncology medication management system developed by Omda, which utilizes clinically validated protocols along with individualized patient parameters to provide safer and more effective treatment for those facing cancer. This groundbreaking solution improves the quality of care for oncology patients by promoting a cohesive and collaborative treatment environment among healthcare providers, including physicians, pharmacists, and nurses. Designed to accommodate a wide spectrum of adult and pediatric cancers, Omda Cytodose supports various treatment modalities such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Originating from a group of clinicians at one of Norway’s leading cancer facilities, the system was launched in 2001 and has since been widely implemented across healthcare sectors in the Nordic countries, facilitating millions of medication orders. With a robust history spanning 15 years characterized by safety, reliability, and stability, Omda Cytodose is carefully tailored with chemotherapy protocols that align with both national and international standards. This ensures that patients are provided with the most current treatment options available, significantly improving their prospects for successful recovery. As a result, the system not only streamlines medication management but also reinforces the importance of interdisciplinary collaboration in cancer care.
Learn more